Long-term safety and efficacy of Omnitrope ®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study

ConclusionsOmnitrope ® appears to be well tolerated and effective for the treatment of a wide range of paediatric indications, which is consistent with the outcomes from controlled clinical trials. These results need to be interpreted with caution until the data from the global PATRO Children study are available.
Source: Italian Journal of Pediatrics - Category: Pediatrics Source Type: research